HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clusterin expression in gastrointestinal neuroendocrine tumours is highly correlated with location and is helpful in determining the origin of liver metastases.

AbstractAIMS:
Clusterin (CLU) is a sulphated glycoprotein implicated in many physiological and pathological processes, including tumorigenesis. We have previously demonstrated that CLU is highly expressed in pancreatic neuroendocrine tumours (NETs). The aims of this study were: to investigate CLU expression in gastrointestinal NETs; the potential correlation between this expression and different clinicopathological parameters; and its usefulness in the differential diagnosis of liver metastases.
METHODS AND RESULTS:
Immunohistochemistry using an anti-CLU antibody was performed on paraffin sections from 108 primary NETs [G3 (13 cases), G2 (18 cases), and G1 (77 cases), according to the 2010 WHO classification] and 60 metastases. Cytoplasmic positivity was scored qualitatively and quantitatively. The pattern of staining was also assessed. Two-step statistical analyses (univariate and multivariate logistic regression) were performed. More than 90% of small-intestine NETs were completely negative. The probability of obtaining a positive CLU score was higher for the appendix, the stomach, the duodenum and the rectum than for the small intestine and colon. All G3 NETs and most G2 NETs were negative as compared with G1. CLU expression in the metastatic foci was identical to that of the primary tumour.
CONCLUSIONS:
Clusterin expression in gastrointestinal NETs is highly correlated with location and probably also with grading, in both the primary tumour and metastases. Underexpression of CLU in small-intestine NETs is helpful for identifying the origin of liver metastases: a strong CLU score in a liver biopsy makes the small intestine highly unlikely as a primary site.
AuthorsNajat Mourra, Aurelie Scriva, Yohann Mansiaux, Sarah Gozlan, Malika Bennis, Andre Balaton
JournalHistopathology (Histopathology) Vol. 65 Issue 5 Pg. 642-50 (Nov 2014) ISSN: 1365-2559 [Electronic] England
PMID24807631 (Publication Type: Journal Article)
Copyright© 2014 John Wiley & Sons Ltd.
Chemical References
  • Biomarkers, Tumor
  • CLU protein, human
  • Clusterin
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers, Tumor (metabolism)
  • Clusterin (metabolism)
  • Female
  • Gastrointestinal Neoplasms (metabolism, pathology)
  • Humans
  • Immunohistochemistry
  • Liver (metabolism, pathology)
  • Liver Neoplasms (metabolism, pathology)
  • Male
  • Middle Aged
  • Neoplasm Metastasis
  • Neuroendocrine Tumors (metabolism, pathology)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: